FDA Drug Recalls

Recalls / Class II

Class IID-0819-2018

Product

Amlodipine and Benazapril HCL Capsules, USP, 5 mg/10 mg, 100 count bottles, Mylan Pharmaceuticals, Inc., Morgantown, WV --- NDC 0378-6896-01

Affected lot / code info
Lot Numbers# 3083005, 3083006, 3086121, and 3086122, exp Jan 2019

Why it was recalled

cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure

Recalling firm

Firm
Mylan Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
781 Chestnut Ridge Rd, Morgantown, West Virginia 26505-2730

Distribution

Quantity
25,488 bottles
Distribution pattern
Product was distributed throughout United States

Timeline

Recall initiated
2018-04-24
FDA classified
2018-05-17
Posted by FDA
2018-05-23
Terminated
2019-06-20
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0819-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.